Kaletra
Product Images NDC 66336-624

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Kaletra (NDC 66336-624). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 66336-0624-xx (Ndc 66336 0624 Xx Abbott)

This is information about a bulk source data for Abbott Pharmaceuticals PR Ltd. The data includes details about their product - yellow ovaloid film-coated tablet (with the logo KA engraved on it) - and the recommended direction for taking the tablet. It also includes details about the lot number, the Product ID, and the manufacturer's details. The text also mentions the possible side-effects of the tablet. Additionally, it lists details about the tablets' dosage, ingredients/content/tablet, RX-only warning, storage conditions, and necessary precautions.*

FDA Label Image

Body Surface Area Equation. (Kaletra Tablets Bsacalculation)

FDA Label Image

Figure Displays Steady-state Plasma Concentrations For Lopinavir And Ritonavir. (Kaletra Tablets Oral Figure1)

This is a table showing concentration values (in ug/mL) at 12 hours for Lopinavir and Ritonavir medications, along with a 95% confidence interval. There is no additional information available.*

FDA Label Image

Chemical Structure For Lopinavir. (Kaletra Tablets Oral Structure1)

FDA Label Image

Chemical Structure For Ritonavir. (Kaletra Tablets Oral Structure2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.